5-Fluorouracil-Induced Coronary Vasospasm

Cancer Control

Volumn 11, Issue 1, 2004, Pages 46-49

  Shoemaker, Laura K ^a   Arora, Umesh ^b   Rocha Lima, Caio Max S ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DILTIAZEM; FLUOROURACIL; FOLINIC ACID; GLYCERYL TRINITRATE; HEPARIN; IRINOTECAN; ISOSORBIDE MONONITRATE; NITROPRUSSIDE SODIUM; OXALIPLATIN;

ADJUVANT CHEMOTHERAPY; ADULT; ANGINA PECTORIS; ARTICLE; CASE REPORT; COLON CANCER; COLON RESECTION; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY SPASM; DIAPHORESIS; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; HEART CATHETERIZATION; HUMAN; INTRACORONARY INFUSION; MALE; METASTASIS; NAUSEA; ST SEGMENT ELEVATION; VOMITING;

EID: 2342646039     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480401100107     Document Type: Article

References (12)

1. Sobrero AF, Aschele C, Bertino JR. Fluorouracil in colorectal cancer: a tale of two drugs. Implications for biochemical modulation. J Clin Oncol. 1997;15:368-381.
2. Robben NC, Pippas AW, Moore JO. The syndrome of 5-fluorouracil cardiotoxicity: an elusive cardiopathy. Cancer. 1993;71:493-509.
3. Schober C, Papageorgiou E, Harstrick A, et al. Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancer. Cancer. 1993;72:2242-2247.
4. de Forni M, Malet-Martino MC, Jaillais P, et al. Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study. J Clin Oncol. 1992;10:1795-1801.
5. Keefe DL, Roistacher N, Pierri MK. Clinical cardiotoxicity of 5-fluorouracil. J. Clin Pharmacol. 1993;33:1060-1070.
6. Kleiman NS, Lehane DE, Geyer CE Jr, et al. Prinzmetal's angina during 5-fluorouracil chemotherapy. Am J Med. 1987;82:566-568.
7. Lestuzzi C, Viel E, Picano E, et al. Coronary vasospasm as a cause of effort-related myocardial ischemia during low-dose chronic continuous infusion of 5-fluorouracil. Am J Med. 2001;111:316-318.
8. Maseri A, Lanza G. Fluorouracil-induced coronary artery spasm. Am J Med. 2001;111:326-327.
9. Mosseri M, Fingert HJ, Varticovski L, et al. In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle. Cancer Res. 1993;53:3028-3033.
10. André T, Louvet C, Maindrault-Goebel F, et al. CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLIRI) for pretreated metastatic colorectal cancer. GERCOR. Eur J Cancer. 1999;35:1343-1347.
11. O'Connell MJ, Martenson JA, Wieand HS, et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med. 1994;331:502-507.
12. Akpek G, Hartshorn KL. Failure of oral nitrate and calcium channel blocker therapy to prevent 5-fluorouracil-related myocardial ischemia: a case report. Cancer Chemother Pharmacol. 1999;43:157-161.